Search
forResearch 10 of 337
- Dermatologic adverse events associated with afatinib: an oral ErbB family blocker
- Targeted expression of activated erbB-2 to the epidermis of transgenic mice elicits striking developmental abnormalities in the epidermis and hair follicles.
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Epiregulin promotes hair growth via EGFR‐medicated epidermal and ErbB4‐mediated dermal stimulation
- Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis
- Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways
- Loss of ERBB2 and ERBB3 Receptors Impacts Epidermal Differentiation in Mice
- Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic mice
- Beyond Wavy Hairs
- Epidermal Growth Factor as a Biologic Switch in Hair Growth Cycle
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →